| Literature DB >> 36233522 |
Florian Richter1, Anne-Sophie Mehdorn1, Thorben Fedders1, Benedikt Reichert1, Jan-Hendrik Egberts2, Thomas Becker1, Julius Pochhammer1.
Abstract
INTRODUCTION: The value of C-reactive protein (CRP) as a predictor of anastomotic leakage (AL) after esophagectomy has been addressed by numerous studies. Despite its increasing application, robotic esophagectomy (RAMIE) has not been considered separately yet in this context. We, therefore, aimed to evaluate the predictive value of CRP in RAMIE.Entities:
Keywords: C-reactive protein; CRP; Ivor-Lewis; PIC; RAMIE; complications; esophageal cancer; esophagus; minimally invasive surgery; postoperative infectious complications; robotic esophagectomy; robotic surgery
Year: 2022 PMID: 36233522 PMCID: PMC9571314 DOI: 10.3390/jcm11195654
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Baseline characteristics of patients undergoing RAMIE (n = 160) or OE (n = 145) stratified by surgical approach. Data are presented as mean ± SD, range or relative frequencies. Continuous variables were tested using a Students’ t-test (normally distributed) and b Mann-Whitney-U test (non-normally distributed). ASA: American Society of Anaesthesiologists; BMI: body mass index, OE: open esophagectomy, PIC: postoperative infectious complications; POD: postoperative day; RAMIE: Robot-assisted minimally-invasive esophagectomy, SD: Standard deviation. p-values < 0.05 were considered statistically significant and are indicated in bold.
| RAMIE | OE | ||
|---|---|---|---|
| Sex (male [ | 131 [81.9] | 116 [80.0] | 0.63 b |
| Age (years [mean ± SD]) | 64.0 ± 9.3 | 65.2 ± 10.3 | 0.29 a |
| BMI (kg/m2, [mean ± SD]) | 26.6 ± 4.8 | 26.6 ± 5.2 | 0.97 a |
| Smoking (yes [ | 57 [35.6] | 45 [31.0] | 0.70 b |
| ASA ≥ 3 (yes [ | 107 [66.9] | 96 [66.2] | 0.90 b |
| Entity [ | 0.05 b | ||
| Adenocarcinoma | 141 [88.1] | 113 [66.2] | |
| Squamous cell carcinoma | 15 [9.4] | 23 [15.9] | |
| Other | 4 [2.5] | 9 [6.2] | |
| Procedure [ | <0.001 a | ||
| Ivor-Lewis | 146 [88.1] | 108 [75.5] | |
| Transhiatal oesophagectomy | 5 [3.1] | 29 [20.0] | |
| McKeown | 9 [5.6] | 8 [5.5] | |
| Length of surgery | 329.3 ± 74.1 | 293.0 ± 89.5 | <0.010 a |
| Neoadjuvant treatment [ | |||
| Radiotherapy | 44 [27.5] | 25 [17.2] | 0.03 b |
| Chemotherapy | 123 [76.9] | 86 [59.3] | <0.01 b |
| Adjuvant treatment [ | |||
| Radiotherapy | 5 [3.1] | 10 [7.2] | 0.11 b |
| Chemotherapy | 65 [42.2] | 46 [38.7] | 0.55 b |
| PIC (yes [ | 64 (40.0) | 59 (40.7) | 0.09 b |
| Length of hospital stay | 20.5 | 19 | 0.59 b |
Figure 1Flow-Chart of the inclusion of the study. HMIE: Hybrid minimally invasive esophagectomy, MIE: minimally invasive esophagectomy, NonPic: non-postoperative infectious complications, PIC: postoperative infectious complications, RAMIE: Robot-assisted minimally invasive esophagectomy, OE: open esophagectomy.
PIC of patients undergoing RAMIE (n = 160) or OE (n = 145). Data are presented as number [relative frequencies] if not other stated, CDC Center for Disease Control; PIC: postoperative infectious complications, POD: postoperative day. Continuous variables were tested using a Students’ t-test (normally distributed) and b Mann-Whitney-U test (non-normally distributed), while categorical variables were compared using c Chi-Square.
| Postoperative Infectious Complications | ||||
|---|---|---|---|---|
| All | RAMIE | OE | ||
| PIC (POD10) (yes [ | 91 [29.8] | 41 [25.6] | 50 [34.5] | 0.09 c |
| PIC (POD30) (yes [ | 123 [40.3] | 64 [40.0] | 59 [40.7] | 0.90 a |
| Pneumonia (yes [ | 72 [23.6] | 35 [21.9] | 37 [25.5] | 0.45 a |
| Surgical Side infections (yes [ | 15 [4.9] | 3 [1.9] | 12 [8.3] | 0.01 c |
| Gastric conduit leakage (yes [ | 10 [3.3] | 6 [3.8] | 4 [2.8] | 0.63 c |
| Gastric conduit necrosis (yes [ | 9 [3.0] | 7 [4.4] | 2 [1.4] | 0.12 c |
| Anastomotic leakage (yes [ | 90 [29.5] | 49 [30.6] | 41 [28.3] | 0.65 c |
| Esophagobronchial Fistula (yes [ | 15 [4.9] | 10 [6.3] | 5 [3.4] | 0.26 c |
| CDC (yes [ | 84 [29.5] | 44 [27.5] | 40 [27.6] | 0.14 c |
| Readmission (POD 30) (yes [ | 33 [10.8] | 14 [8.8] | 19 [13.1] | 0.22 c |
| Recurrence (yes [ | 81 [26.7] | 38 [23.9] | 43 [29.9] | 0.24 c |
| Death (yes [ | 90 [29.5] | 56 [35.0] | 93 [64.1] | <0.001 c |
| Follow up (months, [median, range]) | 17.5 (0–144) | 12 (0–106) | 27 (0–144) | <0.001 a |
Baseline and perioperative characteristics of patients undergoing RAMIE (n = 160) or OE (n = 145) stratified by PIC within 30 days after surgery. Data are presented as mean ± SD, range or relative frequencies. Continuous variables were tested using a Students’ t-test (normally distributed) and b Mann-Whitney-U test (non-normally distributed), while categorical variables were compared using c Chi-Square. ASA: American Society of Anaesthesiologists; BMI: body mass index, OE: open esophagectomy, PIC: postoperative infectious complications; POD: postoperative day; RAMIE: Robot-assisted minimally-invasive esophagectomy, SD: Standard deviation. p-values < 0.05 were considered statistically significant and are indicated in bold.
| Postoperative Infectious Complication until POD 30 | |||
|---|---|---|---|
| NoPIC | PIC | ||
| Sex (male [ | 149 [48.9] | 98 [39.7] | 0.63 c |
| Age (years [mean ± SD]) | 64.4 ± 9.9 | 64.8 ± 9.7 | 0.73 a |
| BMI (kg/m2, [mean ± SD]) | 26.2 ± 4.8 | 27.3 ± 5.3 | 0.08 a |
| Smoking (yes [ | 57 [18.7] | 45 [14.8] | 0.15 c |
| ASA ≥ 3 (yes [ | 126 [41.3] | 77 [25.3] | 0.23 c |
| Entity [ | 0.56 c | ||
| Adenocarcinoma | 155 [50.8] | 99 [32.5] | |
| Squamous cell carcinoma | 20 [6.6] | 18 [5.9] | |
| Other | 7 [2.3] | 6 [2.0] | |
| Surgical approach [ | |||
| RAMIE | 96 [31.8] | 64 [21.0] | 0.90 c |
| OE | 86 [28.2] | 59 [19.3] | |
| Procedure [ | 0.83 c | ||
| Ivor-Lewis | 153 [50.2] | 101 [33.1] | |
| Transhiatal oesophagectomy | 20 [6.6] | 14 [4.6] | |
| McKeown | 9 [3.0] | 8 [2.6] | |
| Length of surgery | 310.4 ± 81.2 | 314.7 ± 87.3 | 0.66 c |
| Neoadjuvant treatment [ | |||
| Radiotherapy | 38 [12.5] | 31 [10.2] | 0.38 c |
| Chemotherapy | 129 [42.3] | 80 [26.2] | 0.28 c |
| Adjuvant treatment [ | |||
| Radiotherapy | 11 [3.7] | 4 [1.4] | 0.28 c |
| Chemotherapy | 80 [29.3] | 31 [11.4] | <0.001 c |
| Length of hospital stay | 14 (6–58) | 39 (1–171) | <0.001 b |
Postoperative CRP- and PCT-values of all patients included stratified by the development of PIC (NoPIC vs. PIC). CRP: C-reactive protein, PCT: Procalcitonin, PIC: postoperative infectious complications, POD: postoperative day. Continuous variables were tested using the Students’ t-test (normally distributed). p-values < 0.05 were considered statistically significant and are indicated in bold.
| CRP | NoPIC | PIC | PCT | NoPIC | PIC | ||
|---|---|---|---|---|---|---|---|
| POD 1 | 84.5 ± 38.4 | 93.5 ± 42.7 | 0.07 | POD 1 | 1.4 ± 2.9 | 2.1 ± 5.2 | 0.24 |
| POD 2 | 155.5 ± 68.0 | 177.5 ± 69.1 | <0.01 | POD 2 | 1.1 ± 1.7 | 2.8 ± 11.9 | 0.23 |
| POD 3 | 141.1 ± 70.5 | 186.3 ± 84.1 | <0.01 | POD 3 | 0.9 ± 1.2 | 2.4 ± 5.8 | 0.06 |
| POD 4 | 107.0 ± 65.2 | 170.0 ± 84.6 | <0.01 | POD 4 | 1.2 ± 2.6 | 2.9 ± 10.1 | 0.26 |
| POD 5 | 81.9 ± 70.5 | 150.7 ± 86.0 | <0.01 | POD 5 | 1.0 ± 2.2 | 3.6 ± 11.4 | 0.12 |
| POD 2-1 | 70.9 ± 50.9 | 87.3 ± 57.8 | 0.02 | ||||
| POD 3-2 | −15.3 ± 47.4 | 12.7 ± 52.9 | <0.01 | ||||
| POD 4-3 | −37.9 ± 40.9 | −23.4 ± 50.0 | 0.02 |
Figure 2Postoperative CRP-values of patients undergoing RAMIE (n = 160) (a) or OE (n = 145) (b) stratified by development of PIC (NoPIC vs. PIC). CRP: C-reactive protein, PIC: postoperative infectious complications, POD: postoperative day, ns: no significance, *: p = 0.01, **: p ≤ 0.01.
Figure 3Postoperative CRP-values of patients with PIC (a) or without PIC (b) stratified by surgical approach. CRP: C-reactive protein, OE: open esophagectomy, POD: postoperative day, RAMIE: robot-assisted minimally invasive esophagectomy, ns: no significance, **: p ≤ 0.01.
Univariate logistic regression of CRP-levels depending on postoperative infectious complications and type of procedure. AUC and ROC-analysis to evaluate the prediction of a PIC. Best cut-off means the highest Youden’s index.
| Odds Ratio | Cut-Off | AUC | NPV | PPV | |||
|---|---|---|---|---|---|---|---|
|
| POD 4 | 1.01 |
| 168.0 | 0.73 | 73.9 | 65.2 |
| POD 5 | 1.01 |
| 70 | 0.70 | 83.7 | 59.3 | |
|
| POD 4 | 1.01 |
| 88.3 | 0.74 | 80.4 | 58.9 |
| POD 5 | 1.01 |
| 142.0 | 0.73 | 71.1 | 78.6 |
AUC: Area under the curve; CRP: C-reactive protein (mg/L); NPV: negative predictive value; POD: postoperative day; PPV: positive predictive value; ROC: receiver operating characteristic (ROC). p-values < 0.05 were considered statistically significant and are indicated in bold.